Samuel Allemann
Cited by
Cited by
Pharmaceutical care: the PCNE definition 2013
SS Allemann, JWF van Mil, L Botermann, K Berger, N Griese, ...
International journal of clinical pharmacy 36, 544-555, 2014
Matching adherence interventions to patient determinants using the theoretical domains framework
SS Allemann, R Nieuwlaat, BJF Van den Bemt, KE Hersberger, I Arnet
Frontiers in pharmacology 7, 429, 2016
Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials …
SS Allemann, R Nieuwlaat, T Navarro, B Haynes, KE Hersberger, I Arnet
Journal of clinical epidemiology 91, 70-79, 2017
TEOS: A framework for constructing operational definitions of medication adherence based on Timelines–Events–Objectives–Sources
AL Dima, SS Allemann, J Dunbar‐Jacob, DA Hughes, B Vrijens, IB Wilson
British journal of clinical pharmacology 87 (6), 2521-2533, 2021
Issues around the prescription of half tablets in Northern Switzerland: the irrational case of quetiapine
SS Allemann, D Bornand, B Hug, KE Hersberger, I Arnet
BioMed research international 2015 (1), 602021, 2015
Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data
H Rouzé, M Viprey, S Allemann, AL Dima, P Caillet, A Denis, ...
Patient preference and adherence, 1497-1510, 2019
Beyond adherence thresholds: a simulation study of the optimal classification of longitudinal adherence trajectories from medication refill histories
SS Allemann, D Dediu, AL Dima
Frontiers in pharmacology 10, 383, 2019
Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting
SS Allemann, KE Hersberger, I Arnet
Integrated Pharmacy Research and Practice, 167-174, 2015
Methodological considerations on estimating medication adherence from self‐report, electronic monitoring and electronic healthcare databases using the TEOS framework
AL Dima, SS Allemann, J Dunbar‐Jacob, DA Hughes, B Vrijens, IB Wilson
British Journal of Clinical Pharmacology 89 (7), 1918-1927, 2023
A guide to a pharmacist-led pharmacogenetic testing and counselling service in an interprofessional healthcare setting
CK Stäuble, C Jeiziner, A Bollinger, FM Wiss, M Hatzinger, KE Hersberger, ...
Pharmacy 10 (4), 86, 2022
Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): Study protocol for an open-label, randomized controlled trial
CK Stäuble, ML Lampert, S Allemann, M Hatzinger, KE Hersberger, ...
Trials 22, 1-11, 2021
National poison center calls before vs after availability of high-dose acetaminophen (paracetamol) tablets in Switzerland
A Martinez-De la Torre, S Weiler, DS Bräm, SS Allemann, ...
JAMA network open 3 (10), e2022897-e2022897, 2020
AdhereR: an open science approach to estimating adherence to medications using electronic healthcare databases
A Dima, S Allemann, D Dediu
MEDINFO 2019: Health and Wellbeing e-Networks for All, 1451-1452, 2019
Adherence patterns in antiseizure medications influencing risk of sudden unexplained death in epilepsy: a data linkage study using dispensed prescriptions
M Tan, SS Allemann, XS Qin, WJ D'Souza
Epilepsia 64 (3), 641-653, 2023
Swiss priority setting on implementing medication adherence interventions as part of the European ENABLE COST action
C Bandiera, J Ribaut, AL Dima, SS Allemann, K Molesworth, K Kalumiya, ...
International journal of public health 67, 1605204, 2022
Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study
F Dietrich, A Zeller, S Allemann, I Arnet
BMJ Open Quality 12 (1), e002155, 2023
Pharmacogenetic analysis enables optimization of pain therapy: a case report of ineffective oxycodone therapy
FM Wiss, CK Stäuble, HE Meyer zu Schwabedissen, SS Allemann, ...
Journal of Personalized Medicine 13 (5), 829, 2023
Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
CK Stäuble, R Meier, ML Lampert, T Mikoteit, M Hatzinger, SS Allemann, ...
Frontiers in Psychiatry 13, 942268, 2022
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis?–A Case Report
C Jeiziner, SS Allemann, KE Hersberger, HE Meyer zu Schwabedissen
Pharmacogenomics and Personalized Medicine, 465-475, 2022
Utilization of drugs with pharmacogenetic dosing recommendations in Switzerland: a descriptive study using the helsana database
NL Wittwer, CR Meier, CA Huber, HE Meyer zu Schwabedissen, ...
Pharmacogenomics and Personalized Medicine, 967-976, 2022
The system can't perform the operation now. Try again later.
Articles 1–20